STOCK TITAN

Simulations Plus to Present at Raymond James Institutional Investors Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Simulations Plus, a leader in biosimulation software, will present at the Raymond James 43rd Annual Institutional Investors Conference from March 6-9, 2022, in Orlando, Florida. CEO Shawn O’Connor is scheduled to present on March 9 at 10:25 a.m. ET and will conduct one-on-one meetings. Attendance is by invitation only. The presentation will be available on the Simulations Plus Investors page. This conference is a key event for engaging with institutional investors and showcasing advancements in pharmaceutical modeling and simulation.

Positive
  • None.
Negative
  • None.

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that management will be presenting at the Raymond James & Associates’ 43rd Annual Institutional Investors Conference, scheduled for March 6-9, 2022, at the JW Marriott Grande Lakes in Orlando, Florida.

Shawn O’Connor, chief executive officer, will present on Wednesday, March 9, 2022, at 10:25 a.m. ET in Palazzo H. In addition, Mr. O’Connor will be available to host one-on-one meetings throughout the day.

The conference is by invitation only, so to attend the conference or request a one-on-one meeting, please contact your Raymond James representative. The Company’s presentation will be available on the Investors page of the Simulations Plus website. For more information about the Raymond James Institutional Investors Conference, please visit the Raymond James website or contact Brian Siegel from Hayden IR at brian@haydenir.com.

About Simulations Plus

Serving clients worldwide for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn.

Environmental, Social, and Governance (ESG)

We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report

Simulations Plus Investor Relations

Ms. Renee Bouche

661-723-7723

renee.bouche@simulations-plus.com

Hayden IR

Mr. Brian Siegel

(346) 396-8696

brian@haydenir.com

Source: Simulations Plus, Inc.

FAQ

When is Simulations Plus presenting at the Raymond James Conference 2022?

Simulations Plus is presenting on March 9, 2022, at 10:25 a.m. ET.

Where is the Raymond James Institutional Investors Conference held in 2022?

The conference is held at the JW Marriott Grande Lakes in Orlando, Florida.

Who is presenting for Simulations Plus at the conference?

Shawn O’Connor, the CEO of Simulations Plus, will be presenting.

How can I attend the Raymond James Conference for Simulations Plus?

Attendance is by invitation only; contact your Raymond James representative for more information.

Where can I find the presentation by Simulations Plus from the conference?

The presentation will be available on the Simulations Plus Investors page following the conference.

Simulations Plus, Inc.

NASDAQ:SLP

SLP Rankings

SLP Latest News

SLP Stock Data

629.91M
16.42M
18.14%
77.89%
4.88%
Health Information Services
Services-computer Integrated Systems Design
Link
United States of America
LANCASTER